198 related articles for article (PubMed ID: 1980007)
1. Preferential loss of maternal alleles in sporadic Wilms' tumour.
Pal N; Wadey RB; Buckle B; Yeomans E; Pritchard J; Cowell JK
Oncogene; 1990 Nov; 5(11):1665-8. PubMed ID: 1980007
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity in Wilms' tumour involves two distinct regions of chromosome 11.
Wadey RB; Pal N; Buckle B; Yeomans E; Pritchard J; Cowell JK
Oncogene; 1990 Jun; 5(6):901-7. PubMed ID: 2163053
[TBL] [Abstract][Full Text] [Related]
3. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour.
Ogawa O; Eccles MR; Szeto J; McNoe LA; Yun K; Maw MA; Smith PJ; Reeve AE
Nature; 1993 Apr; 362(6422):749-51. PubMed ID: 8097018
[TBL] [Abstract][Full Text] [Related]
4. Genetic mosaicism in normal tissues of Wilms' tumour patients.
Chao LY; Huff V; Tomlinson G; Riccardi VM; Strong LC; Saunders GF
Nat Genet; 1993 Feb; 3(2):127-31. PubMed ID: 8388768
[TBL] [Abstract][Full Text] [Related]
5. Nonrandom loss of maternal chromosome 11 alleles in Wilms tumors.
Schroeder WT; Chao LY; Dao DD; Strong LC; Pathak S; Riccardi V; Lewis WH; Saunders GF
Am J Hum Genet; 1987 May; 40(5):413-20. PubMed ID: 2883892
[TBL] [Abstract][Full Text] [Related]
6. Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma.
Zbar B; Brauch H; Talmadge C; Linehan M
Nature; 1987 Jun 25-Jul 1; 327(6124):721-4. PubMed ID: 2885753
[TBL] [Abstract][Full Text] [Related]
7. Intragenic homozygous deletion of the WT1 gene in Wilms' tumor.
Tadokoro K; Fujii H; Ohshima A; Kakizawa Y; Shimizu K; Sakai A; Sumiyoshi K; Inoue T; Hayashi Y; Yamada M
Oncogene; 1992 Jun; 7(6):1215-21. PubMed ID: 1350671
[TBL] [Abstract][Full Text] [Related]
8. The familial Wilms' tumour susceptibility gene, FWT1, may not be a tumour suppressor gene.
Rahman N; Arbour L; Tonin P; Baruchel S; Pritchard-Jones K; Narod SA; Stratton MR
Oncogene; 1997 Jun; 14(25):3099-102. PubMed ID: 9223674
[TBL] [Abstract][Full Text] [Related]
9. Molecular and cellular biology of Wilms' tumour.
Maitland NJ; Brown KW; Poirier V; Shaw AP; Williams J
Anticancer Res; 1989; 9(5):1417-26. PubMed ID: 2556071
[TBL] [Abstract][Full Text] [Related]
10. A third Wilms' tumor locus on chromosome 16q.
Maw MA; Grundy PE; Millow LJ; Eccles MR; Dunn RS; Smith PJ; Feinberg AP; Law DJ; Paterson MC; Telzerow PE
Cancer Res; 1992 Jun; 52(11):3094-8. PubMed ID: 1317258
[TBL] [Abstract][Full Text] [Related]
11. Familial predisposition to Wilms' tumour does not map to the short arm of chromosome 11.
Grundy P; Koufos A; Morgan K; Li FP; Meadows AT; Cavenee WK
Nature; 1988 Nov; 336(6197):374-6. PubMed ID: 2848199
[TBL] [Abstract][Full Text] [Related]
12. p57K1P2 is expressed in Wilms' tumor with LOH of 11p15.5.
Overall ML; Spencer J; Bakker M; Dziadek M; Smith PJ
Genes Chromosomes Cancer; 1996 Sep; 17(1):56-9. PubMed ID: 8889507
[TBL] [Abstract][Full Text] [Related]
13. Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour.
Steenman MJ; Rainier S; Dobry CJ; Grundy P; Horon IL; Feinberg AP
Nat Genet; 1994 Jul; 7(3):433-9. PubMed ID: 7920665
[TBL] [Abstract][Full Text] [Related]
14. 16q heterozygosity loss in Wilms' tumour in children and its clinical importance.
Skotnicka-Klonowicz G; Rieske P; Bartkowiak J; Szymik-Kantorowicz S; Daszkiewicz P; Debiec-Rychter M
Eur J Surg Oncol; 2000 Feb; 26(1):61-6. PubMed ID: 10718182
[TBL] [Abstract][Full Text] [Related]
15. Molecular analysis of the chromosome 11p region in renal cell carcinomas.
Kovacs G; Kiechle-Schwarz M; Scherer G; Kung HF
Cell Mol Biol; 1992 Feb; 38(1):59-62. PubMed ID: 1348450
[TBL] [Abstract][Full Text] [Related]
16. Genetic and epigenetic alterations on the short arm of chromosome 11 are involved in a majority of sporadic Wilms' tumours.
Satoh Y; Nakadate H; Nakagawachi T; Higashimoto K; Joh K; Masaki Z; Uozumi J; Kaneko Y; Mukai T; Soejima H
Br J Cancer; 2006 Aug; 95(4):541-7. PubMed ID: 16909133
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity in Wilms' tumors, studied for six putative tumor suppressor regions, is limited to chromosome 11.
Mannens M; Devilee P; Bliek J; Mandjes I; de Kraker J; Heyting C; Slater RM; Westerveld A
Cancer Res; 1990 Jun; 50(11):3279-83. PubMed ID: 2159377
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity for the short arm of chromosome 7 in sporadic Wilms tumour.
Grundy RG; Pritchard J; Scambler P; Cowell JK
Oncogene; 1998 Jul; 17(3):395-400. PubMed ID: 9690521
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of E-cadherin and cadherin-11 in Wilms' tumours.
Schulz S; Becker KF; Braungart E; Reichmuth C; Klamt B; Becker I; Atkinson M; Gessler M; Höfler H
J Pathol; 2000 Jun; 191(2):162-9. PubMed ID: 10861576
[TBL] [Abstract][Full Text] [Related]
20. Molecular nature of genetic changes resulting in loss of heterozygosity of chromosome 11 in Wilms' tumours.
Mannens M; Slater RM; Heyting C; Bliek J; de Kraker J; Coad N; de Pagter-Holthuizen P; Pearson PL
Hum Genet; 1988 Dec; 81(1):41-8. PubMed ID: 2848758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
